Groesbeek, Netherlands

Susan Allegonda Maria Mulders

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Susan Allegonda Maria Mulders: Innovator in RNA Modulation

Introduction

Susan Allegonda Maria Mulders is a prominent inventor based in Groesbeek, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of RNA modulating oligonucleotides. With a total of two patents to her name, her work focuses on addressing neuromuscular disorders through innovative genetic solutions.

Latest Patents

Mulders' latest patents include groundbreaking research on RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders. The current invention provides an improved oligonucleotide and its use for treating, ameliorating, preventing, delaying, and/or treating human cis-element repeat instability associated with genetic neuromuscular or neurodegenerative disorders. This advancement holds promise for enhancing therapeutic options for patients suffering from these conditions.

Career Highlights

Throughout her career, Mulders has worked with notable companies in the biotechnology sector. She has been associated with Biomarin Technologies B.V. and Vico Therapeutics B.V., where she has contributed her expertise in RNA modulation and genetic research. Her work has been instrumental in advancing the understanding and treatment of complex genetic disorders.

Collaborations

Mulders has collaborated with various professionals in her field, including her coworker, Peter Christian De Visser. These collaborations have fostered innovation and have been crucial in the development of her patented technologies.

Conclusion

Susan Allegonda Maria Mulders is a trailblazer in the field of RNA modulation, with her inventions paving the way for new treatments for neuromuscular disorders. Her dedication to research and innovation continues to impact the biotechnology landscape positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…